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Abstract.  The plasma membrane of murine erythro- 
leukemia (MEL) cells contains a  140-kD protein that 
binds specifically to fibronectin. A  '25I-labeled 140-kD 
protein from surface-labeled uninduced MEL ceils 
was specifically bound by an affinity matrix that con- 
tained the 115-kD cell binding fragment of fibronec- 
tin, and specifically eluted by a synthetic peptide that 
has cell attachment-promoting activity. The loss of 
this protein during erythroid differentiation was corre- 
lated with loss of cellular adhesion to fibronectin. 
Both MEL cells and reticulocytes attached to the same 
site on fibronectin as do fibroblasts since adhesion of 
erythroid cells to fibronectin was specifically blocked 
by a monoclonal antibody directed against the cell- 
binding fragment of fibronectin and by a synthetic 
peptide containing the Arg-Gly-Asp-Ser sequence 
found in the cell-binding fragment of fibronectin. 
Erythroid cells attached specifically to surfaces coated 
either with the 115-kD cell-binding fragment of fibro- 
nectin or with the synthetic peptide-albumin complex. 
Thus, the erythroid 140-kD protein exhibits several 
properties in common with those described for the 
fibronectin receptor of fibroblasts. We propose that 
loss or modification of this protein at the cell surface 
is responsible for the loss of cellular adhesion to fibro- 
nectin during erythroid differentiation. 
RING erythropoiesis,  plasma membrane proteins of 
he nucleated erythroblasts are  replaced by mem- 
brane proteins of the mature erythrocyte. In mam- 
mals, the synthesis of erythrocyte membrane proteins spec- 
trin, the anion-exchange protein Band III, and glycophorin is 
completed well  before  the  non-nucleated reticulocytes are 
released from the bone marrow into the circulation (4, 9, 10, 
17).  Erythroid differentiation also  involves elimination of 
glycoproteins characteristic  of  erythroblasts, such as the trans- 
ferrin  receptor  (24). Recently we  showed that  uninduced 
murine erythroleukemia (MEL)' cells, reticulocytes  from ane- 
mic rabbits,  and erythrocytes from splenectomized mice at- 
tach tightly and specifically to immobilized fibronectin (25, 
26). Adhesion to fibronectin is lost upon dimethyl sulfoxide- 
induced erythroid differentiation of MEL cells in vitro, and 
upon maturation of reticulocytes to erythrocytes in vivo. 
Fibronectin is a disulfide-linked dimeric glycoprotein that 
is associated with extracellular matrices of many tissues, and 
a soluble form is found in the plasma. It has been implicated 
in numerous biological processes including cell adhesion (13), 
cellular differentiation (32, 42), and morphogenetic events (2, 
3). Each of the similar but not identical 220-kD  subunits of 
fibronectin contains several  protease-resistant  domains that 
t Abbreviations  used  in  this  paper.  MEL,  murine erythroleukemia; NRK, 
normal rat kidney; PMSF, phenylmethylsulfonyl  fluoride;  WGA, wheat germ 
agglutinin. 
represent functional binding sites for collagen (gelatin), fibrin, 
heparin, and cell surface receptors  involved in the adhesion 
of cells to  fibronectin (16,  45). Adhesion of fibroblasts  to 
fibronectin involves the recognition of a  tetrapeptide, Arg- 
Gly-Asp-Ser, which is found within the  115-kD cell-binding 
domain (28, 46). 
Several types of plasma membrane components have been 
proposed to serve the function of fibronectin receptor (re- 
viewed  in reference  47). Photoaffinity cross-linking  experi- 
ments reveal that chondroitin sulfate proteoglycans (27) and 
a  47-kD glycoprotein (1) are associated  with fibronectin at 
the cell surface. Membrane glycolipids are also implicated in 
cell-fibronectin  interactions. Sialic acid-rich gangliosides in- 
hibit  cell  attachment  (18,  48).  Several  investigators  have 
shown that antibodies that interfere with cell adhesion rec- 
ognize cell  surface  glycoproteins in the  140-kD  range (re- 
viewed in reference 6). Recently, the cell-binding domain of 
fibronectin was used as an affinity matrix to identify putative 
receptors  in human MG-63 osteosarcoma cells and normal 
rat kidney (NRK) cells (33). Liposomes containing a 140-kD 
glycoprotein isolated from these cells attach specifically to 
fibronectin. 
Fibronectin is a major component of the extracellular ma- 
trix in the bone marrow (43, 49). We postulated that some of 
the membrane components that mediate adhesion of eryth- 
rocyte precursors  to fibronectin are lost in the bone marrow, 
whereas  the  rest  are  lost in  the  spleen  as the  reticulocyte 
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the  region  of the  fibronectin  molecule  recognized  by  the 
erythrocyte  precursors  and  the  cell  surface  receptors  that 
mediate such interactions remained unknown. We show here 
that MEL cells and rabbit reticulocytes attach to the same site 
on fibronectin as do fibroblasts. Affinity chromatography was 
used to identify a putative fibronectin receptor in uninduced 
MEL cells.  This  140-kD protein was not detected in  MEL 
cells after 4  d  of differentiation.  We  propose that  loss  or 
modification of this protein at the cell surface is responsible 
for the loss of cellular adhesion to fibronectin during erythroid 
differentiation. 
Materials and Methods 
Materials 
Cyanogen bromide-activated  Sepharose 4B,  a-chymotrypsin  type VII, N,-p- 
tosyI-L-lysine chloromethylketone  (TLCK),  phenylmethylsulfonyl  fluoride 
(PMSF), and wheat  germ agglutinin (WGA) were all purchased  from Sigma 
Chemical Co., St. Louis, MO. Lactoperoxidase and octyI-B-D-glucopyranoside 
were purchased from Calbiochem-Behring Corp., San Diego, CA. Monoclonal 
antibodies  against  human plasma  fihronectin  were purchased  from Mallin- 
ckrodt Inc., St. Louis, MO. Peptide I was synthesized by the Peptide Synthesiz- 
ing Facility  in the  Department of Chemistry,  University  of California,  San 
Diego. Peptide  II was a  gift from Dr.  Samuel  H.  Barondes,  University  of 
California,  San  Diego. Peptides  III, IV, and  V were purchased  from Sigma 
Chemical Co. The structures of these peptides are shown in Table lI. 
Preparation of  Fibronectin Fragments and Peptide 
1-Albumin Complex 
Fibronectin  was purified from outdated  human plasma by gelatin-Sepharose 
affinity chromatography  according to Engvall and Ruoslahti (8). The 115-kD 
cell-binding and 45-kD gelatin-binding  fragments were isolated from a chy- 
motryptic digest of fibronectin according to Ruoslahti et al. (35). These fibro- 
nectin  fragments  were  purified  to >95%  homogeneity  by gel  filtration  on 
Sephadex G-200 and Sephacryl S-200 columns. Synthetic peptide 1 containing 
[t4C]alanine in its sequence was further purified by Sephadex G- 15 gel filtration 
chromatography,  and its sequence was confirmed  by quantitative  amino acid 
analyses. Peptide 1  was cross-linked to bovine albumin (peptide/albumin  molar 
ratio, 50:1) with fresh glutaraldehyde as described (41). After the remaining free 
aldehyde groups were blocked with glycine, the peptide-albumin  complex was 
isolated by gel filtration on a Sephadex G-25 column.  The efficiency of cross- 
linking, calculated  from the amount of radiolabeled peptide  recovered with 
albumin, was -62%. 
Cell Culture and Induction of  Anemia 
MEL cells were grown in suspension culture  in Dulbecco's  modified Eagle's 
medium supplemented  with  13% heat-inactivated  fetal bovine serum. Induc- 
tion  of MEL  cell differentiation  by  dimethyl  sulfoxide was carried  out  as 
described (25). NRK fibroblasts were grown in Dulbecco's  modified  Eagle's 
medium.  Reticulocytes were obtained  from rabbits made anemic by phenyl- 
hydrazine injection (34). In brief, New Zealand White rabbits, 2.5-3.5 kg, were 
injected subcutaneously with freshly prepared 2% phenylhydrazine hydrochlo- 
ride (Eastman  Kodak  Co., Rochester,  NY) solution  in PBS according to the 
following schedule: 2 ml on day  1, 2 ml on day 2,  1.5 ml on day 4, and 1 ml 
on day 6. The rabbit was bled on day 8. 
For cell adhesion assays, MEL and NRK ceils were metabolically labeled by 
incubation  in Dulbecco's  modified Eagle's medium containing  30 pCi/ml of 
[3SS]methionin¢ (Amersbam Corp., Arlington Heights, IL) for 30 h at 37°C in 
a tissue culture  incubator.  Reticulocytes  were first washed three  times  with 
Hanks' balanced salt solution as described (26). Approximately  5 x  10  ~ retie- 
ulocytes were incubated in 2 ml leucine-free Eagle's minimum essential medium 
containing 20 mM Hepes, 10 mM inosine, 5 mM adenosine,  10 mg/ml bovine 
albumin,  and 30 ~Ci/ml [~H]leucine (Amersham Corp.) for  I h at 37"C in a 
tissue culture incubator. 
Cell A ttachment Assays 
The cell adhesion  assays were performed  in  96-well polystyrene  microtiter 
plates (Linbro)  according to Ruoslahti  et al. (36). In brief, wells were coated 
with fibronectin by incubating 0.1  ml of fibronectin  at 5 pg]ml in phosphate- 
buffered saline (PBS; 10 mM sodium phosphate,  150 mM NaCI, pH 7.5) for 1 
h  at  22-24"C.  The remaining  protein  adsorption  sites were saturated  with 
albumin by incubation  with 0.1 ml of a 10 mg/ml solution of fibronectin-frec 
albumin for an additional  30 min. In some experiments, wells were coated with 
the peptide l-albumin  complex instead of fibronectin, and the free sites were 
blocked with albumin as described  above.  To determine  the  effect of anti- 
fibronectin  monoclonal antibodies on cell attachment,  we preincubated  fibro- 
nectin-coated  wells with 0.1  ml of adhesion  medium (Dulbecco's  modified 
Eagle's medium without  serum,  but supplemented  with  2  mg/ml albumin) 
containing  monoclonal  antibody  for  6  h  at  4"C. Approximately  104  [3sS]- 
methionine-labeled  NRK  and  MEL  cells and  3  x  104  [3H]leucine-labeled 
reticulocytes suspended in 0.1  ml adhesion medium were added to each well. 
Cells were allowed to attach  in the presence of antibody  for 45 rain at 37"C. 
The unattached  cells were washed away and the trichloroacetic acid-precipita- 
ble  radioactivity  in  the attached  fraction  was determined  by counting  in  a 
scintillation spectrophotometer.  The cell adhesion promoting activity ofpeptide 
I was measured by incubating cells in wells that had been coated with peptide 
l-albumin complex and glutaraldehyde-treated albumin (control) for 60 min at 
37"C. After unattached  cells were washed away, radioactivity in the attached 
fraction was determined  as above. 
Cell Surface Labeling 
Uninduced  and 4-d-induced MEL ceils were washed four times with ice-cold 
Hank's balanced salt solution  containing  20 mM Hepes buffer (wash buffer). 
Approximately  108 washed cells were suspended in 3 ml Hanks' balanced salt 
solution and iodinated according to Sefton et al. (38) in the presence of 3 mCi 
~251-sodium iodide (100 mCi/ml; Amersham Corp.) and 0.29 mg/ml of lacto- 
peroxidase. After 30 min of incubation  on ice, cells were washed three times 
with wash buffer containing  5 mM sodium iodide and 2 mM PMSF, and once 
with column buffer (10 mM sodium phosphate,  150 mM NaCI, 1 mM CaCI2, 
1 mM MgCI2, pH 7.5). Cells were lysed in  1 ml of column buffer containing 
200 mM octylglucoside, 2 mM PMSF, and  1 mM N,-p-tosyl-L-lysine chloro- 
methylketone  by vortexing for 30 sec and incubating  on ice for 20 rain.  The 
cell extract was centrifuged at 13',000 g for 15 rain at 4°C to remove insoluble 
cytoskeletal and nuclear components.  In some experiments,  a suspension  of 
rabbit erythrocytes (t0% hematocrit) in Hanks' balanced salt solution was also 
iodinated as above. 
Isolation of  Fibronectin Receptor 
The 115-kD cell-binding fragment of fibronectin was immobilized  on CNBr- 
activated Sepharose 4B beads according to the technical handbook of  Pharmacia 
Fine  Chemicals,  Piscataway,  NJ.  About 4  mg of the  115-kD fragment  of 
fibronectin was bound per ml Sepharose. 
The detergent  extract  of labeled  cells was  subjected  to  l l5-kD  affinity 
chromatography  according to Pytela et al: (33). in brief,  1 ml of cell extract 
was applied to I ml of affinity matrix that had been equilibrated with column 
buffer containing 50 mM octylglucoside, 1 mM PMSF, and 1 mM No-p-tosyl- 
L-lysine chloromethylketone  (starting buffer). Material unbound to the column 
was recovered upon washing the column with 3 ml of starting buffer. Bound 
components were eluted  by washing the column sequentially  with  2  ml of 
starting buffer containing  1 mg/ml of peptide IV, 1 mg/ml of peptide I, and 6 
ra urea. 0.5-ml fractions were collected, and aliquots (25 pl) were mixed with 
an equal  volume  of Laemmli  (20) gel sample buffer, boiled  for 3 rain,  and 
subjected  to  SDS  PAGE  analysis.  For autoradiography,  the  dried  gel  was 
exposed to Kodak  XAR X-ray film with an intensifying screen for  1-2 d at 
-70"C. 
Results 
Inhibition of Cell Attachment by Anti-Fibronectin 
Monoclonal A ntibody 
Adhesion  of fibroblasts to  immobilized fibronectin can  be 
blocked by antisera to fibronectin (14).  In our initial studies 
we  used  a  panel  of monoclonal  antibodies  raised  against 
human plasma fibronectin to identify domains of the fibro- 
nectin molecule involved in the adhesion of MEL cells and 
reticulocytes. These antibodies bind to different parts of the 
fibronectin molecule  2 (reference 7 and Fig.  1). 
2 McDonald, J.A.  Personal communication. 
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Figure  1.  A model of a  fibronec- 
tin dimer showing the relative po- 
sitions  of various  functional  do- 
mains  and  proteolytic  cleavage 
sites. Also shown are the regions of 
fibronectin  molecule  recognized 
by various monoclonal antibodies 
(N293,  N294,  N295,  and  N296) 
used in this study; after Hynes and 
Yamada (16) and Pierschbacher et 
al.  (30).  CHT,  chymotrypsin, 
TRY, trypsin, and PEP, pepsin. 
Antibody N294  recognizes a  pepsin  cleavage site  at  the 
amino-terminus  of the  l l.5-kD  cell  adhesion  fragment  of 
fibronectin. 2 It inhibited adhesion of MEL cells and reticulo- 
cytes to  fibronectin  (Fig.  2,  B  and  C).  This  antibody also 
inhibited the adhesion of NRK fibroblasts to fibronectin (Fig. 
2A). The degree of inhibition was dependent on the cell type: 
50%  inhibition  of MEL cell  and  reticulocyte adhesion  oc- 
curred at 7 pg of antibody per ml, and of NRK cells at 3 #g/ 
ml (Fig. 2).  The inhibitory effect of the N294 antibody was 
specific, since antibodies N293 and N296 that recognize other 
parts of  the fibronectin molecule did not perturb cell adhesion 
(Fig. 2).  Antibody N295 binds to the  11.5-kD cell adhesive 
fragment of fibronectin and inhibits cell adhesion weakly.  2 In 
our assays, we could not detect any effects on cell attachment 
(Fig. 2). 
Identification of  MEL Cell and Reticulocyte-binding 
Domains of  Fibronectin 
Adhesion of fibroblasts to immobilized fibronection  occurs 
primarily by interaction with the  115-kD chymotryptic frag- 
ment that contains the cell-binding domain of the fibronectin 
and that lacks other known binding activities of the molecule 
(28). This fragment and the 45-kD gelatin-binding fragment 
were  purified  from the  chymotryptic digest  of fibronectin. 
Both  MEL  cells  and  reticulocytes  attached  specifically  to 
dishes coated with intact fibronectin and its  115-kD chymo- 
tryptic fragment, but not to dishes coated with bovine serum 
albumin or the gelatin-binding fragment of fibronectin (Table 
I). As expected,  a  similar specificity of attachment was ob- 
served with NRK cells (Table I).  Thus, MEL ceils,  reticulo- 
cytes, and fibroblasts attach to the  115-kD cell binding do- 
main of fibronectin. 
Localization of the MEL Cell and Reticulocyte 
Attachment Site on Fibronectin 
Adhesion of fibroblasts to fibronectin is mediated by the Arg- 
Gly-Asp-Ser sequence located at the carboxy-terminal portion 
of the 115-kD chymotryptic fragment of fibronectin (30). To 
determine whether this amino acid sequence is also involved 
in the adhesion of MEL cells and reticulocytes, we used two 
types of assays. First, we determined the capacity of synthetic 
peptides to inhibit attachment of cells to a  substrate coated 
with  intact  fibronectin.  Second, we determined directly the 
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Figure 2.  Effect of anti-fibronectin  monoclonal antibodies  on cell 
attachment.  Adhesion of NRK (A), MEL (B), and reticulocytes (C) 
to fibronectin-coated wells in the presence of the indicated amounts 
of antibodies was measured as described in Materials and Methods. 
In albumin-coated  wells, <10% of the plated cells attached either in 
the presence or absence of antibodies  (not shown). Data shown are 
means of values derived from quadruplet  assays done at each indi- 
cated concentration of the antibody. Cell attachment in the presence 
of each of the antibodies N293, N295, N296 (O), and N294 (,) was 
measured in parallel experiments. Maximum attachment of cells to 
fibronectin in the absence of  antibodies was ~50% of the plated cells, 
and this is normalized to 100%. 
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cross-linking the peptide to albumin with glutaraldehyde. 
As shown  in  Table  II,  fibronectin-mediated  adhesion  of 
MEL cells and reticulocytes was inhibited by an octapeptide 
(peptide I) that contains the Arg-Gly-Asp-Ser sequence. Half- 
maximal inhibition of attachment occurred at ~70 pg/ml. A 
pentapeptide  (peptide  II)  containing  Arg-Gly-Asp-Ala  se- 
quence was also inhibitory. Adhesion of these cells to fibro- 
nectin was maximally (>90%) inhibited by both the peptides 
at  200  pg/ml  (data  not  shown).  As expected,  adhesion  of 
NRK  cells  to  fibronectin  was  inhibited  by  both  peptides 
(Table  II). Three other nonrelated peptides (III, IV, and V; 
Table II) did not interfere with cell adhesion.  Inhibition of 
cell attachment is probably not due to the cytotoxicity of the 
peptides,  since >90%  of the cells  recovered after the assay 
were viable as determined by trypan blue exclusion. 
Table I.  Uninduced MEL Cells and Rabbit Reticulocytes 
Attach to Cell-binding Domain of Fibronectin 
Attached (%) 
Additions  NRK  MEL  Reticulocytes 
BSA  5  5  3 
Intact fibronectin  95  90  45 
Cell binding domain  87  81  40 
Gelatin binding domain  6  5  6 
Falcon petri dishes (35-mm diam, Falcon Labware,  Oxnard, CA) were coated 
with 2 ml bovine serum albumin (BSA) at  10 mg/ml, intact fibronectin at 6 
#g/ml, the 115-kD cell-binding fragment of fibronectin at  10 ug/ml, and the 
45-kD gelatin-binding fragment of fibronectin at  12 pg/ml as described else- 
where (26). Approximately 1 ×  105 NRK and MEL cells and 1 x  106 red cells 
from an anemic rabbit (which contained 50% reticulocytes)  in 2 ml adhesion 
medium were incubated at 37"C for 1 h. Unattached cells were washed away. 
The attached cells were detached by a 5-min incubation in 0.2% trypsin/0.02% 
EDTA  at  37"C  and  counted  in  the Coulter Counter (Coulter  Electronics, 
Hialeah, FL). Anemia was induced in rabbits by repeated bleeding; the blood 
contained  ~50%  reticulocytes and  ~80%  of the  cells  that  attached  were 
reticulocytes  as judged by new methylene blue staining. Data presented are 
mean for three replicate dishes. 
Table II.  Effects of Synthetic Peptides on Attachment  of 
Cells to Immobilized Fibronectin 
Concentration for half- 
maximal inhibition 
(pg/ml) 
When  cross-linked  to  albumin,  peptide  I  also  promoted 
adhesion of cells to plastic surface. MEL cells,  reticulocytes, 
and  NRK  cells  attached  specifically  to  wells  coated  with 
peptide-albumin  complex, but not to wells coated with glu- 
taraldehyde-treated  albumin  (Fig.  3).  Erythrocytes  do  not 
attach to fibronectin (26), nor do they attach to wells coated 
with  peptide  I-albumin  complex  or glutaraldehyde-treated 
albumin (Fig.  3B).  Albumin coupled to a  nonrelated tetra- 
peptide Gly-Pro-Arg-Pro did not promote cell adhesion (data 
not shown). Adhesion of cells to peptide I-albumin complex 
was dose  dependent:  half-maximal  adhesion  of NRK cells 
and MEL cells was observed at ~2 pg peptide, whereas half- 
maximal attachment of reticulocytes occurred at  l0 pg (Fig. 
3).  These results indicate that most MEL cells and reticulo- 
cytes attach to the same Arg-Gly-Asp-Ser sequence of fibro- 
nectin implicated in the interaction with fibroblasts. 
Detection and Developmental Regulation of a Cell 
Surface Fibronectin-binding Proteins 
Since erythroid differentiation of MEL cells is accompanied 
by a dramatic loss of cellular adhesion to fibronectin, loss of 
adhesion probably results from the loss or modification of a 
cell surface fibronectin receptor (25). To identify and isolate 
a putative fibronectin receptor in these cells we used affinity 
chromatography, an approach described recently for the iso- 
lation of the fibronectin receptor from fibroblasts (33).  Un- 
induced or 4-d dimethyl sulfoxide-induced cells were surface- 
labeled with 125I by extracellular lactoperoxidase. An octylglu- 
coside extract of these cells was then applied to a column of 
Sepharose to which was coupled the  115-kD cell attachment 
fragment  of fibronectin.  Specific elution  of bound compo- 
nents was achieved by washing with peptide I. 
A  140-kD protein  labeled  on  uninduced  MEL cells  was 
bound to the column and specifically eluted by peptide I (Fig. 
4A,  lanes  8-11).  A  minor  70-kD  protein  band  was  also 
detected.  No  significant elution  of the  140-kD protein  oc- 
curred when the column was washed with a nonrelated pep- 
tide that lacks cell attachment-promoting activity (Fig.  4A, 
lanes 4-7). Low amounts of  the 140-kD protein were detected 
in column washes obtained before elution with the peptides 
Reticu-  ~00 
Peptides  Amino acid sequence  NRK  MEL  locytes 
e0 
I  Octapeptide  Gly-Arg-Gly-Asp-  52  60  70 
Ser-Pro-Ala-Ser. 
II  Pentapeptide  Arg-Gly-Asp-Ala-  60  80  85 
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III  Fibrinopeptide-A  Ala-Asp-Ser-Gly-  >700  >700  >700 
Glu-Gly-Asp-Phe- 
Leu-Ala-Glu-Gly- 
Giy-Gly-Val-Arg. 
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Pro-lie. 
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Cell  attachment assay was performed in polystyrene microtiter wells coated 
with 5 ug/ml plasma fibronectin. Approximately 104 [35Slmethionine-labeled 
NRK  and  MEL  cells  and  3  ×  104  [3H]leucine-labeled  reticulocytes were 
incubated at 37"C in the presence of various concentrations of peptides. After 
30 min, unattached cells were washed away and the radioactivity in the attached 
cell fraction was determined as described in experimental procedures. Indicated 
concentrations of peptides are means of values derived from two  separate 
experiments. Maximum attachment in the absence of peptides was ~50% of 
the cells plated. 
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Figure  3.  Attachment of cells 
to microtiter wells coated with 
synthetic  peptide  I-albumin 
complex  (Gly-Arg-Gly-Asp- 
Ser-Pro-Ala-Ser). A suspension 
of  104  labeled  NRK  or  MEL 
cells (A)  and  3  x  10  4 rabbit 
reticulocytes  (B)  in  0.2  ml 
adhesion  medium  was  incu- 
bated in each well for 1 h. Ap- 
proximately  3  x  10  4 cell-sur- 
face iodinated  rabbit  erythro- 
cytes (B) were also incubated 
in parallel. Wells coated  with 
albumin  or  glutaraldehyde- 
treated  albumin  alone did not 
promote  significant  attach- 
ment of cells. Data shown are 
means of values obtained from 
two  separate  experiments.  O, 
NRK  fibroblasts  and  rabbit 
erythrocytes; O, MEL cells and 
rabbit reticulocytes. 
The Journal of Cell Biology, Volume 102, 1986  452 Figure  4.  Autoradiogram  of an SDS PAGE of components eluted from a Sepharose column to which the  115-kD cell binding  fragment of 
fibronectin  was coupled.  Affinity chromatography of extracts  of ~25I-labeled uninduced  (A) and 4-d induced  MEL cells (B) was done as 
described in Materials and Methods.  An aliquot  of each  fraction was subjected to electrophoresis on  10% acrylamide gels under reducing 
conditions.  Arrows indicate initiation  of elution with synthetic peptides IV and I. Lane 1, membranes  from surface-labeled erythrocytes used 
as molecular  weight marker;  lane 2, bulk  of the unbound components recovered in the column flow-through; lane 3, fraction  obtained  by 
washing with starting buffer just before elution with the peptides; lanes 4-7, eluted with 1 mg/ml peptide IV; lanes 8-11, eluted with 1 mg/ml 
peptide  I; and lanes 12 and 13, 6 M urea eluates. The position of the erythrocyte ankyrin (200 kD) band III protein (100 kD) and actin (43 
kD) are shown as visualized by Coomassie Blue staining of the gel. The position of the 140-kD  protein band is indicated by an arrowhead. 
(Fig. 4A, lane 3), as was observed with fibroblasts by Pytela 
et al. (33). The  140-kD protein was quantitatively eluted by 
peptide I, since little was eluted upon subsequent washing of 
the column with urea (Fig. 4, lanes 12-13).  In other similar 
experiments, proteins eluted from the column were visualized 
by silver staining of  the gel (not shown). Among other minor, 
nonradioactive  proteins,  the  140-kD  protein  was  clearly  a 
major component in  peptide  I  eluates.  Since the elution  of 
these minor components was not specifically affected by the 
peptide I, we conclude that these minor proteins were non- 
specifically adsorbed by the column. No specific protein bands 
were  eluted  when  bovine  albumin  and  the  45-kD  gelatin- 
binding fragment of fibronectin were used as affinity matrices 
(data not shown). 
After 4 d  of differentiation induced by dimethyl sulfoxide, 
~80%  of the MEL cells did not attach to fibronectin-coated 
dishes (not shown). When extracts of 125I-labeled induced cells 
were  chromatographed  on  a  Sepharose  column  containing 
the cell-binding domain of  fibronectin, no radioactivity bound 
that was specifically eluted by peptide I (Fig. 4B).  In partic- 
ular,  the  140-kD protein  was barely detected in  any of the 
column eluates (Fig. 4, lanes 3-13).  Minute amounts of the 
140-kD protein can be seen in Fig. 4B lane 9, but only after 
longer exposures (not shown). Essentially similar results were 
obtained when detergent extracts of the total membrane frac- 
tion of induced cells was iodinated by chloramine-T and used 
as the starting material for affinity chromatography (data not 
shown).  Thus,  the  apparent  loss  of the  140-kD  protein  in 
differentiated  MEL cell  cultures correlated  with the  loss of 
cellular adhesion to fibronectin. 
Affinity-purifed  140-kD  protein  from  uninduced  MEL 
cells was quantitatively bound by WGA-Sepharose and was 
eluted from this affinity column by N-acetylglucosamine (Fig. 
5, lanes 1-3). This was true even for the much smaller amount 
of  protein present in the 4-d induced cells (Fig. 5, lane 7). No 
binding to concanavalin A-Sepharose was observed for the 
140-kD protein from either uninduced or induced cells (not 
shown).  When  the  140-kD  protein  was  subjected  to  SDS 
PAGE under nonreducing conditions, a  major band at  120 
kD and a  minor band at  140 kD were resolved (Fig. 6, lane 
1). Thus, the  140-kD protein is a glycoprotein and has prop- 
erties similar to those described for the fibroblast fibronectin 
receptor (33). 
Discussion 
We  have  shown  that  the  plasma  membrane  of uninduced 
MEL cells contains a  140-kD protein that binds specifically 
to fibronectin and that its loss during erythroid differentiation 
correlates with a loss of cellular adhesion to fibronectin. The 
140-kD protein  is  similar  in  size to  the  putative  fibroblast 
fibronectin receptor, and both erythroid cells and fibroblasts 
appear to bind to the same small region of fibronectin. 
A small segment of fibronectin, called the cell attachment 
domain,  mediates the  interaction  of fibronectin  with  fibro- 
blasts (31), platelets (11), and human macrophages (44). Using 
several  approaches  we  have  shown  that  this  segment  also 
promotes adhesion of MEL cells and reticulocytes to plastic 
surfaces. The adhesion of erythroid cells to fibronectin-coated 
surfaces was specifically blocked by a  monoclonal antibody 
453  Patel, Lodish  Fibronectin  Receptor  and Erythrocyte  Differentiation Figure 5.  Autoradiogram ofa SDS PAGE analysis of  fractions eluted 
from the WGA-Sepharose 4B affinity columns.  Synthetic peptide  I 
eluates obtained from the experiment shown in Fig. 4, A (0-d induced 
cells) and B (4-d induced)  were chromatographed  on 0.5-ml  (bed 
volume) WGA-Sepharose affinity column.  Bound components were 
eluted with the column buffer containing 50 mM octylglucoside, 200 
mM  N-acetylglucosamine,  1 mM  PMSF, and  1 mM Na-p-tosyl-L- 
lysine chloromethylketone.  0.25-ml fractions were collected, and 25- 
/~1 aliquots of each fraction were subjected to electrophoresis on 10% 
acrylamide gels under reducing conditions.  Lanes 1-3 and 6-8, N- 
acetylglucosamine eluates; lanes 4, 5,  9, and 10, 6 M urea  eluates. 
Molecular  weight  markers  used  here  were  myosin  (200  kD),  ~- 
galactosidase (116 kD), bovine albumin  (66 kD), and ovalbumin (45 
kD). 
directed  against  the  cell-binding  fragment  of  fibronectin. 
Erythroid cells attached specifcally to dishes coated with pure 
115-kD cell-binding fragment of flbronectin, and the attach- 
ment  of erythroid  cells  to  fibronectin-coated  surfaces  was 
specifically inhibited  by a  synthetic  peptide  containing the 
Arg-Gly-Asp-Ser sequence found in the cell-binding fragment 
of fibronectin. A synthetic peptide, peptide II, containing an 
Arg-Gly-Asp-Ala sequence was also inhibitory. This sequence 
exists  in  a  variety  of nonrelated  proteins  and  also  inhibits 
fibroblast  attachment  (29).  Thus,  we  have  confirmed  that 
substitution  of a  serine  residue  by alanine  in  the  Arg-Gly- 
Asp-Ser sequence does not significantly diminish its inhibitory 
effect on cell attachment. As with fibroblasts (46), inhibition 
of attachment  by the  peptides  appeared  to  be  competitive 
because the  inhibitory effect of the  peptide  declined as the 
amount of fibronectin preadsorbed on the plastic surface was 
increased (data not shown). 
MEL cells and reticulocytes attached specifically to dishes 
coated  with  peptide  I  cross-linked  to  albumin  (Fig.  3).  In 
contrast to promoting 90%  attachment  of NRK fibroblasts 
and reticulocytes, the immobilized peptide I promoted attach- 
ment  of only 60%  of the  MEL  cells.  Intact  fibronectin  or 
its  I15-kD  cell-binding  fragment  promoted  attachment  of 
>80%  of the  MEL cells (Table  1).  Thus,  in spite of a  large 
relative  molar excess  of peptide  I  as  compared with  intact 
fibronectin adsorbed  onto the dish,  less MEL cell adhesion 
occurred. This difference in efficiency of cell adhesion might 
be due to the divalence of intact fibronectin or to the hetero- 
geneity of the MEL cell culture. Alternatively, it may reflect 
the contribution of cell surface molecules that recognize ad- 
ditional  sites on the  I 15-kD cell-binding fragment of fibro- 
nectin. Indeed, a  variant of Arg-Gly-Asp-Ser sequence (Arg- 
Gly-Asp-Val) has been predicted to occur in some fibronectin 
subunits as a result of alternative RNA splicing (37, 39), and 
peptides  containing  such  a  sequence  have  cell  adhesion- 
promoting activity (29). 
The  140-kD glycoprotein present  on the  surface of MEL 
cells exhibited properties required of a flbronectin receptor. It 
was specifically bound by the affinity matrix that contained 
the  115-kD cell-binding fragment of fibronectin and specifi- 
cally eluted by a peptide that has cell attachment-promoting 
activity. The 140-kD protein binds to WGA. This agrees with 
the observations of Pytela et al. (33), who showed that lipo- 
somes containing the 140-kD WGA-binding protein, purified 
from fibroblasts, attached specifically to fibronectin. Antibod- 
ies raised against WGA-binding components of baby hamster 
kidney fibroblasts have been shown to inhibit attachment of 
these cells to fibronectin, and a 48-kD WGA-binding protein 
has been implicated in the adhesion of these cells to fibronec- 
tin (23).  However, no cell surface adhesive molecule of this 
size was found in our studies. Several investigators have shown 
that antibodies that interfere with the adhesion of various cell 
types to  fibronectin  recognize glycoproteins in  the  140-kD 
range (5,  15,  19, 22,  40),  The  140-kD protein of MEL cells 
migrates on SDS PAGE as  120- and  140-kD species under 
nonreducing conditions (Fig. 6). The reasons for the increased 
mobility of the nonreduced receptor proteins are not known. 
Figure 6.  Autoradiogram  shows SDS PAGE analysis of the  140-kD 
protein  under nonreducing  conditions.  125I-labeled 140-kD proteins 
eluted from the WGA-Sepharose column (Fig. 5, lane 2) and molec- 
ular weight markers  were analyzed by SDS PAGE (8% acrylamide 
gels) under nonreducing (lane 1) and reducing (lane 2) conditions on 
two separate gels. Molecular weight markers visualized by Coomassie 
Blue staining of gels were myosin (200 kD), ~-galactoside (100 kD), 
phosphorylase b (97 kD), bovine  albumin  (66 kD), ovalbumin  (45 
kD), carbonic anhydrase (29 kD), and lysozyme (14 kD). 
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native protein stabilized by internal disulfide bonds may be 
responsible for its increased mobility under nonreducing con- 
ditions (33).  Similar properties have been described for the 
fibroblast fibronectin receptor (5,  12, 33, 40). To what extent 
these receptor molecules are related to the erythroid 140-kD 
protein described here remains to be determined. 
The amount of surface-labeled 140-kD protein that can be 
specifically bound to the fibronectin affinity column declined 
during  MEL  cell  differentiation  and  was  barely  detectable 
after 4  d  of differentiation. The loss of the  140-kD protein 
correlated with the loss of cellular adhesion to  fibronectin 
during differentiation. Loss of this protein may occur by an 
endocytotic mechanism, since spectrin-free surface invagina- 
tions and intracellular vesicles have been found in differen- 
tiated erythroleukemia cells (21).  It is also possible that the 
140-kD protein remained on the cell surface but was modified 
so that it did not bind to fibronectin. If so, this modification 
also prevented its binding to WGA, since no labeled 140-kD 
protein was detectable when a  detergent extract of surface- 
iodinated differentiated cells was directly subjected to WGA- 
affinity chromatography (not shown). Cell surface carbohy- 
drate  moieties  have  been  implicated  in  the  interaction  of 
fibronectin with other cell types (18, 45). Thus, it is possible 
that alterations of carbohydrates bound to the 140-kD protein 
during differentiation might result in its failure to bind to the 
cell attachment fragment of fibronectin as well as to WGA. 
The physiologic significance of the loss or modification of 
the 140-kD fibronectin-binding protein during erythroid dif- 
ferentiation remains to be established.  The mechanisms in- 
volved  in  the  release  of the  differentiated  cells  from  the 
interstitial  matrix  of the  bone  marrow  are  complex.  We 
previously suggested that some of the cell surface fibronectin- 
binding sites that mediate adhesion of erythrocyte precursors 
to fibronectin are lost in the bone marrow, whereas the rest 
are lost in the spleen or at some other sites during maturation 
of reticulocytes to erythrocytes (26).  It will be important to 
characterize the cell surface components involved in the in- 
teraction of the erythrocyte precursors of the bone marrow 
with the fibronectin. These interactions should be studied in 
detail since the 140-kD protein can be purified. 
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